Literature DB >> 10674948

Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity?

W Maier1, M Gänsicke, H J Freyberger, M Linz, R Heun, Y Lecrubier.   

Abstract

OBJECTIVE: Generalized anxiety disorder (GAD) is a common psychiatric disorder. The nosological status of this diagnostic entity was critically discussed because of the very high rate of comorbidity with other psychiatric disorders, the assumed low degree of social disability associated with GAD in the absence of other disorders, and an ambigious definition.
METHOD: We explored the frequency and associated social disability of GAD, and examined whether the ICD-10 definition of GAD is appropriate. The analysis was based on the WHO study on 'Psychological Problems in Primary Care' conducted in a standardized manner in 14 countries.
RESULTS: We found GAD (total and without another psychiatric disorder) to be common in primary care in nearly all countries (mean 1-month prevalence rate, 7.9%), with about 25% of these cases presenting with GAD in the absence of any comorbid psychiatric disorder. GAD in general, as well as non-comorbid GAD, are associated with social disability which is as severe as that in chronic somatic diseases.
CONCLUSION: It remains questionable whether the current ICD-10 diagnosis of GAD defining 6 months as a minimum duration and requiring at least four associated symptoms for diagnosis is the most appropriate option. Using this definition, a substantial proportion of psychosocially disabled subjects characterized by anxiety, tension and worrying remain undetected, and are possibly therefore not adequately treated.

Entities:  

Mesh:

Year:  2000        PMID: 10674948     DOI: 10.1034/j.1600-0447.2000.101001029.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  23 in total

1.  Human and economic burden of GAD, subthreshold GAD, and worry in a primary care sample.

Authors:  Sarah J Kertz; Janet Woodruff-Borden
Journal:  J Clin Psychol Med Settings       Date:  2011-09

2.  High anxiety is associated with an increased risk of death in an older tri-ethnic population.

Authors:  Glenn V Ostir; James S Goodwin
Journal:  J Clin Epidemiol       Date:  2006-01-23       Impact factor: 6.437

3.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

4.  Diagnostic comorbidity in adults with generalized anxiety disorder: impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses.

Authors:  Michelle G Newman; Amy Przeworski; Aaron J Fisher; Thomas D Borkovec
Journal:  Behav Ther       Date:  2009-06-08

5.  Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication.

Authors:  Ayelet Meron Ruscio; Wai Tat Chiu; Peter Roy-Byrne; Paul E Stang; Dan J Stein; Hans-Ulrich Wittchen; Ronald C Kessler
Journal:  J Anxiety Disord       Date:  2006-11-21

Review 6.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

7.  Prevalence of anxiety among women attending a primary care clinic in Malaysia.

Authors:  Sherina Mohd Sidik; Bruce Arroll; Felicity Goodyear-Smith
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

8.  Effective Recognition and Treatment of Generalized Anxiety Disorder in Primary Care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

9.  Measurement of problems in activities and participation in patients with anxiety, depression and schizophrenia using the ICF checklist.

Authors:  Rosalía Tenorio-Martínez; María del Carmen Lara-Muñoz; María Elena Medina-Mora
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-01-27       Impact factor: 4.328

10.  Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries.

Authors:  S Lee; A Tsang; A M Ruscio; J M Haro; D J Stein; J Alonso; M C Angermeyer; E J Bromet; K Demyttenaere; G de Girolamo; R de Graaf; O Gureje; N Iwata; E G Karam; J-P Lepine; D Levinson; M E Medina-Mora; M A Oakley Browne; J Posada-Villa; R C Kessler
Journal:  Psychol Med       Date:  2008-12-18       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.